Aureus Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,647
Closed -$204K 182
2020
Q2
$204K Buy
+2,647
New +$203K 0.02% 159
2020
Q1
Sell
-3,558
Closed -$231K 163
2019
Q4
$231K Buy
+3,558
New +$232K 0.03% 163
2018
Q1
Sell
-4,832
Closed -$346K 181
2017
Q4
$346K Hold
4,832
0.05% 137
2017
Q3
$391K Buy
+4,832
New +$369K 0.06% 125
2016
Q4
Sell
-4,730
Closed -$374K 169
2016
Q3
$374K Buy
4,730
+1,501
+46% +$122K 0.07% 98
2016
Q2
$269K Buy
+3,229
New +$287K 0.06% 103
2016
Q1
Sell
-4,743
Closed -$480K 120
2015
Q4
$480K Sell
4,743
-710
-13% -$73.9K 0.11% 80
2015
Q3
$535K Buy
5,453
+275
+5% +$30.5K 0.13% 79
2015
Q2
$606K Sell
5,178
-997
-16% -$109K 0.13% 83
2015
Q1
$606K Sell
6,175
-2,242
-27% -$228K 0.14% 80
2014
Q4
$793K Sell
8,417
-74,202
-90% -$7.67M 0.19% 71
2014
Q3
$8.79M Sell
82,619
-2,157
-3% -$211K 2.21% 18
2014
Q2
$7.03M Sell
84,776
-3,385
-4% -$263K 1.76% 28
2014
Q1
$6.25M Sell
88,161
-73,571
-45% -$5.77M 1.6% 30
2013
Q4
$12.1M Buy
161,732
+2,170
+1% +$151K 3.29% 1
2013
Q3
$10M Buy
159,562
+2,290
+1% +$137K 3.43% 1
2013
Q2
$8.06M Buy
+157,272
New +$8.2M 2.89% 1

Other funds holding GILD

Aureus Asset Management's GILD Position: Q3 2020 in Review

Aureus Asset Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,647 shares — an estimated $204K sold.

Aureus Asset Management first reported a position in GILD in Q2 2013 and held it in 17 quarters. The position peaked at $12.1M in Q4 2013. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Aureus Asset Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Aureus Asset Management sold 2,647 Gilead Sciences shares in Q3 2020, an estimated $204K.
  • Aureus Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 17 quarters.
  • Aureus Asset Management's Gilead Sciences position peaked at $12.1M in Q4 2013.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Aureus Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.